Rafael Holdings, Inc. financial data

Symbol
RFL on NYSE
Industry
Pharmaceutical Preparations
Location
520 Broad Street, Newark, NJ
State of incorporation
DE
Fiscal year end
July 31
Latest financial report
10-K - Q2 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.55K % -61.6%
Debt-to-equity 7.14 % +222%
Return On Equity -36.8 % -1805%
Return On Assets -34.4 % -1720%
Operating Margin -16.1K % -199%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 34.4M USD -51%
Common Stock, Value, Issued 8K USD 0%
Weighted Average Number of Shares Outstanding, Basic 23.7M shares +2.07%
Weighted Average Number of Shares Outstanding, Diluted 23.7M shares +2.07%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 637K USD +128%
Cost of Revenue 85K USD
Research and Development Expense 4.17M USD -33.9%
General and Administrative Expense 8.85M USD -0.87%
Operating Income (Loss) -103M USD -582%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -67.3M USD -669%
Income Tax Expense (Benefit) -2.6M USD -866%
Net Income (Loss) Attributable to Parent -34.4M USD -1734%
Earnings Per Share, Basic -1.45 USD/shares -1713%
Earnings Per Share, Diluted -1.45 USD/shares -1713%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.68M USD -87.6%
Accounts Receivable, after Allowance for Credit Loss, Current 426K USD +100%
Other Assets, Current 150K USD +35.1%
Assets, Current 72.5M USD -12.6%
Property, Plant and Equipment, Net 2.12M USD +25.1%
Intangible Assets, Net (Excluding Goodwill) 1.85M USD
Goodwill 3.05M USD
Other Assets, Noncurrent 35K USD +289%
Assets 96.8M USD -2.02%
Accounts Payable, Current 2.56M USD +668%
Accrued Liabilities, Current 1.8M USD +136%
Liabilities, Current 7.51M USD +250%
Deferred Income Tax Liabilities, Net 73K USD
Other Liabilities, Noncurrent 5K USD -90.9%
Liabilities 10.6M USD +381%
Retained Earnings (Accumulated Deficit) -197M USD -17%
Stockholders' Equity Attributable to Parent 82.2M USD -18.1%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 86.3M USD -10.7%
Liabilities and Equity 96.8M USD -2.02%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.13M USD +17.3%
Net Cash Provided by (Used in) Financing Activities 807K USD
Net Cash Provided by (Used in) Investing Activities -6.79M USD -149%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.3M USD -124%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.68M USD -87.6%
Deferred Tax Assets, Valuation Allowance 71.3M USD +40.1%
Deferred Tax Assets, Gross 71.4M USD +40.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -34M USD -1438%
Lessee, Operating Lease, Liability, to be Paid 78K USD
Property, Plant and Equipment, Gross 3.14M USD +22%
Lessee, Operating Lease, Liability, to be Paid, Year Two 58K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 78K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 78K USD
Deferred Tax Assets, Operating Loss Carryforwards 61.2M USD +243%
Unrecognized Tax Benefits 6.22M USD
Additional Paid in Capital 264M USD +3.38%
Operating Leases, Future Minimum Payments, Due in Two Years 666K USD
Amortization of Intangible Assets 51K USD
Depreciation, Depletion and Amortization 17K USD -22.7%
Deferred Tax Assets, Net of Valuation Allowance 2.36M USD -95.4%
Share-based Payment Arrangement, Expense 2.3M USD +4.94%
Operating Leases, Future Minimum Payments, Due in Three Years 19K USD -99.3%
Operating Leases, Future Minimum Payments Due 155K USD -10.9%
Interest Expense 85K USD